Published in Diagn Pathol on July 28, 2015
KLHL21, a novel gene that contributes to the progression of hepatocellular carcinoma. BMC Cancer (2016) 0.78
Biomarker MicroRNAs for Diagnosis, Prognosis and Treatment of Hepatocellular Carcinoma: A Functional Survey and Comparison. Sci Rep (2016) 0.77
Hepatoepigenetic Alterations in Viral and Nonviral-Induced Hepatocellular Carcinoma. Biomed Res Int (2016) 0.75
Circulating microRNAs as Potential Biomarkers of Infectious Disease. Front Immunol (2017) 0.75
Profiling of metastatic small intestine neuroendocrine tumors reveals characteristic miRNAs detectable in plasma. Oncotarget (2017) 0.75
MicroRNA-150 functions as an antioncogenic regulator in osteosarcoma. Oncol Lett (2017) 0.75
MicroRNAs: genomics, biogenesis, mechanism, and function. Cell (2004) 198.59
Oncomirs - microRNAs with a role in cancer. Nat Rev Cancer (2006) 46.47
A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A (2006) 40.09
MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet (2004) 37.83
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Transection of the oesophagus for bleeding oesophageal varices. Br J Surg (1973) 26.26
Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res (2008) 20.59
EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol (2012) 16.93
Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis (1999) 12.31
Widespread microRNA repression by Myc contributes to tumorigenesis. Nat Genet (2007) 10.78
Serum microRNAs are promising novel biomarkers. PLoS One (2008) 8.69
Hepatitis B virus infection. N Engl J Med (2008) 6.92
Plasma microRNAs are promising novel biomarkers for early detection of colorectal cancer. Int J Cancer (2010) 5.57
How microRNAs control cell division, differentiation and death. Curr Opin Genet Dev (2005) 5.22
Diagnosis and treatment of hepatocellular carcinoma. Gastroenterology (2008) 4.73
Downregulation of miR-122 in the rodent and human hepatocellular carcinomas. J Cell Biochem (2006) 4.15
MicroRNA-101, down-regulated in hepatocellular carcinoma, promotes apoptosis and suppresses tumorigenicity. Cancer Res (2009) 3.83
NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw (2009) 3.25
MicroRNA 29b functions in acute myeloid leukemia. Blood (2009) 3.19
MicroRNAs. Cancer J (2008) 2.28
MicroRNA-30d promotes tumor invasion and metastasis by targeting Galphai2 in hepatocellular carcinoma. Hepatology (2010) 1.82
Serum microRNAs as biomarkers for hepatocellular carcinoma in Chinese patients with chronic hepatitis B virus infection. PLoS One (2011) 1.78
Serum miR-18a: a potential marker for hepatitis B virus-related hepatocellular carcinoma screening. Dig Dis Sci (2012) 1.76
Plasma microRNAs as novel biomarkers for early detection of lung cancer. Int J Clin Exp Pathol (2011) 1.73
How should patients with hepatocellular carcinoma be staged? Validation of a new prognostic system. Cancer (2000) 1.68
Circulating microRNAs as biomarkers for hepatocellular carcinoma. J Clin Gastroenterol (2011) 1.62
Serum proteomics and biomarkers in hepatocellular carcinoma and chronic liver disease. Clin Cancer Res (2008) 1.48
Early hepatocellular carcinoma and dysplastic nodules. Semin Liver Dis (2005) 1.29
Serum microRNA-1 and microRNA-122 are prognostic markers in patients with hepatocellular carcinoma. Eur J Cancer (2013) 1.24
miR-137 is frequently down-regulated in gastric cancer and is a negative regulator of Cdc42. Dig Dis Sci (2011) 1.24
microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb. Int J Oncol (2011) 1.18
Micro-RNAs in gastrointestinal and liver disease. Gastroenterology (2008) 1.09
The role of microRNAs in primary liver cancer. Ann Hepatol (2008) 1.08
MicroRNA-150 predicts a favorable prognosis in patients with epithelial ovarian cancer, and inhibits cell invasion and metastasis by suppressing transcriptional repressor ZEB1. PLoS One (2014) 1.03
Relationship between serum alpha-foetoprotein, cirrhosis and survival in hepatocellular carcinoma. Br J Cancer (1981) 0.95
Expression profiling of serum microRNA-101 in HBV-associated chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. Cancer Biol Ther (2014) 0.95
Activation of hepatic stellate cells is suppressed by microRNA-150. Int J Mol Med (2013) 0.91
Increased expression of microRNA-150 is associated with poor prognosis in non-small cell lung cancer. Int J Clin Exp Pathol (2015) 0.87
Guidelines on the diagnosis and treatment of primary liver cancer (2011 edition). Chin Clin Oncol (2012) 0.87
Characterization of HuH6, Hep3B, HepG2 and HLE liver cancer cell lines by WNT/β - catenin pathway, microRNA expression and protein expression profile. Cell Mol Biol (Noisy-le-grand) (2010) 0.86
2004 guidelines for surgical treatment of primary hepatocellular carcinoma. Zhonghua Gan Zang Bing Za Zhi (2005) 0.77